Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Emulating Homogenous Dose Distribution

NCT02225262 is registered in ClinicalTrials.gov with Community Cancer Center, Normal, Illinois as lead sponsor.

NCT NCT02225262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02225262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Emulating Homogenous Dose Distribution
Lead sponsor
Community Cancer Center, Normal, Illinois
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2008
Completion date
December 31, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the prostate, prostate cancer, prostate neoplasm